{
    "nct_id": "NCT06220201",
    "official_title": "A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants With Autoimmune Neurological Diseases: Relapsing Forms of Multiple Sclerosis (RMS), Progressive Forms of Multiple Sclerosis (PMS), or Refractory Myasthenia Gravis (MG).",
    "inclusion_criteria": "Inclusion Criteria\n\n- Relapsing forms of Multiple Sclerosis (RMS) - Cohort 1.\n\ni) Participants must have an Expanded Disability Status Scale (EDSS) of ≥ 3.0 and ≤ 5.5.\n\nii) Participants must have a diagnosis of Multiple Sclerosis (MS) with relapsed/refractory MS or conversion to active secondary progressive multiple sclerosis (aSPMS), and worsening of disease within 12 months prior to Screening and while on treatment with a high-efficacy DMT for at least 6 months.\n\n- Progressive forms of MS - Cohort 2.\n\ni) Participants must have an EDSS ≥ 3.0 and ≤ 6.0.\n\nii) Participants must have a diagnosis of primary progressive multiple sclerosis (PPMS) that is treatment-resistant or diagnosis of inactive secondary progressive multiple sclerosis (iSPMS).\n\n- Myasthenia Gravis - Cohort 3\n\ni)MGFA classification of II-IV at screening\n\nii) Documentation of autoantibodies against AChR or MuSK (historical or at Screening)\n\niii) Refractory disease defined as disease activity on at least 2 immunosuppressants, including steroids, NSIs, or biologics.\n\niv) Has had thymectomy, only if indicated according to current guidelines.\n\nExclusion Criteria\n\n* Cohorts 1 and 2: Participants that cannot complete the 9-Hole Peg Test (9-HPT) in at least 1 hand in <240 seconds unless extenuating medical conditions unrelated to MS prohibit this.\n* Participants that cannot perform a Timed 25-Foot Walk Test (T25FWT) in < 150 seconds.\n* Presence of other confounding peripheral nervous system disorders or other disorders that may impact muscle strength (eg, myositis) or cause weakness, stroke, chronic inflammatory demyelinating polyradiculoneuropathy, Lambert-Eaton myasthenic syndrome.\n* Other protocol-defined Inclusion/Exclusion criteria apply.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 60 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}